NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Raising hopes for disease treatment and prevention, but also the specter of discrimination and "designer genes," genetic testing is potentially one of the most socially explosive developments of our time. This book presents a current assessment of this rapidly evolving field, offering principles for actions and research and recommendations on key issues in genetic testing and screening.
Advantages of early genetic knowledge are balanced with issues associated with such knowledge: availability of treatment, privacy and discrimination, personal decisionmaking, public health objectives, cost, and more. Among the important issues covered:
- Quality control in genetic testing.
- Appropriate roles for public agencies, private health practitioners, and laboratories.
- Value-neutral education and counseling for persons considering testing.
- Use of test results in insurance, employment, and other settings.
Contents
- COMMITTEE ON ASSESSING GENETIC RISKS
- Preface
- Acknowledgments
- Notes
- Executive Summary
- 1. Setting the Stage
- 2. Genetic Testing and Assessment
- 3. Laboratory Issues in Human Genetics
- 4. Issues in Genetic Counseling
- 5. Public Education in Genetics
- 6. Personnel Issues in Human Genetics
- 7. Financing of Genetic Testing and Screening Services
- 8. Social, Legal, and Ethical Implications of Genetic Testing
- 9. Research and Policy Agenda
- APPENDIX A. Workshop Participants
- APPENDIX B. Committee Biographies
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competencies and with regard for appropriate balance.
This report has been reviewed by a group other than the authors according to procedures approved by a Report Review Committee consisting of members of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.
This project was funded by the National Center for Human Genome Research of the National Institutes of Health (Contract No. NO1-HG-0-001) and by the Health Effects Research Program of the Department of Energy (Contract No. DE-FG05-91ER61115; DOE's support does not constitute an endorsement of the views expressed in the report). The Lucille P. Markey Charitable Trust provided supplemental funding of the study. Additional support for this project was provided by independent Institute of Medicine funds.
The Institute of Medicine was chartered in 1970 by the National Academy of Sciences to enlist distinguished members of the appropriate professions in the examination of policy matters pertaining to the health of the public. In this, the Institute acts under both the Academy's 1863 congressional charter responsibility to be an adviser to the federal government and its own initiative in identifying issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute of Medicine.
- NLM CatalogRelated NLM Catalog Entries
- American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.[J Clin Oncol. 2003]American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.American Society of Clinical Oncology. J Clin Oncol. 2003 Jun 15; 21(12):2397-406. Epub 2003 Apr 11.
- Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.[J Clin Oncol. 1996]Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.. J Clin Oncol. 1996 May; 14(5):1730-6; discussion 1737-40.
- Preempting genetic discrimination and assaults on privacy: report of a symposium.[Am J Med Genet A. 2003]Preempting genetic discrimination and assaults on privacy: report of a symposium.Shinaman A, Bain LJ, Shoulson I. Am J Med Genet A. 2003 Aug 1; 120A(4):589-93.
- Review Genetic testing: employability, insurability, and health reform.[J Natl Cancer Inst Monogr. 1995]Review Genetic testing: employability, insurability, and health reform.Rothstein MA. J Natl Cancer Inst Monogr. 1995; (17):87-90.
- Developing a sustainable process to provide quality control materials for genetic testing.[Genet Med. 2005]Developing a sustainable process to provide quality control materials for genetic testing.Chen B, O' Connell CD, Boone DJ, Amos JA, Beck JC, Chan MM, Farkas DH, Lebo RV, Richards CS, Roa BB, et al. Genet Med. 2005 Oct; 7(8):534-49.
- Assessing Genetic RisksAssessing Genetic Risks
Your browsing activity is empty.
Activity recording is turned off.
See more...